Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution
- PMID: 28488971
- PMCID: PMC5919839
- DOI: 10.2450/2017.0277-16
Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution
Abstract
Background: Transfusion of washed platelet concentrates (W-PC) is recommended for some patients, such as those who have had previous severe allergic transfusion reactions. However, we still lack a standardised method for preparing these products. Here, we assessed the effect of a manual washing procedure on in vitro platelet quality and on the transfusion efficacy of W-PCs.
Materials and methods: Buffy coat-derived W-PC in Composol solution were prepared by one-step centrifugation. Platelet activation and function were evaluated before and after washing by means of: (i) CD62 expression by flow cytometry; (ii) platelet aggregation (LTA); and (iii) the VerifyNow® P2Y12 test. A pilot prospective transfusion study was carried out in 11 onco-hematology patients receiving, in a short time, two consecutive transfusions: one with standard PC (S-PC) and one with W-PC. The post-transfusion platelet increment, the 1 h and 24 h corrected count increment (CCI) and occurrence of bleeding events were used as indices of transfusion efficacy.
Results: Platelet recovery in W-PC was 84.8±5.4%. Washing slightly increased platelet activation in W-PC vs pre-washed samples (% CD62+ platelets 23.6±7 vs 14.8±1; p=0.03). As compared to prewash samples, platelet reactivity of W-PC as measured by VerifyNow® P2Y12 was significantly lower with ADP (PRU 32.2±37.7 vs 4.2±2.4, p=0.027), but similar using TRAP. Platelet aggregation responses to TRAP, collagen, ristocetin and arachidonic acid were maintained in W-PC. The pilot transfusion trial showed similar 1 h (13.5±5.6 vs 11.5±7.3, p=0.49) and 24 h (11±7.2 vs 9±6.5, p=0.48) CCI for S-PC and W-PC. Transfusion of W-PC was not associated with an increased number of bleeding events.
Discussion: We have set up a simple method to obtain buffy-coat-derived W-PC, which has minor effects on in vitro platelet quality and transfusion effectiveness. This procedure can be easily implemented in transfusion centres for on-demand preparation of washed platelets.
Conflict of interest statement
The Authors declare no conflicts of interest.
Similar articles
-
Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.Vox Sang. 1996;70(2):69-75. doi: 10.1111/j.1423-0410.1996.tb01296.x. Vox Sang. 1996. PMID: 8801766
-
Comparison of Therapeutic Effect of Apheresis Platelets and Buffy Coat-Derived Platelet Concentrates.Clin Lab. 2024 Aug 1;70(8). doi: 10.7754/Clin.Lab.2024.231149. Clin Lab. 2024. PMID: 39193950 Clinical Trial.
-
Determination in vivo viability of a transfused platelet product by corrected count increment and percentage platelet response.Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017. Pan Afr Med J. 2017. PMID: 28979628 Free PMC article.
-
Preparation, storage and quality control of platelet concentrates.Transfus Apher Sci. 2009 Oct;41(2):97-104. doi: 10.1016/j.transci.2009.07.001. Epub 2009 Aug 20. Transfus Apher Sci. 2009. PMID: 19699153 Review.
-
Platelet concentrates, from whole blood or collected by apheresis?Transfus Apher Sci. 2013 Apr;48(2):129-31. doi: 10.1016/j.transci.2013.02.004. Epub 2013 Mar 25. Transfus Apher Sci. 2013. PMID: 23535511 Review.
Cited by
-
Traditional and emerging technologies for washing and volume reducing blood products.J Blood Med. 2019 Jan 3;10:37-46. doi: 10.2147/JBM.S166316. eCollection 2019. J Blood Med. 2019. PMID: 30655711 Free PMC article. Review.
References
-
- Tobian AA, Savage WJ, Tisch DJ, et al. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion. 2011;51:1676–83. - PubMed
-
- Azuma H, Hirayama J, Akino M, et al. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol) Transfusion. 2009;49:214–8. - PubMed
-
- Fung MK, Grossman BJ, Hillyer C, et al. Technical Manual. 18th ed. Bethesda, MD: AABB Press; 2014.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials